Study measures para-phenylenediamines in infant formulas, assessing intakes and health risks for infants, suggesting dietary implications.
Para- phenylenediamines (PPDs) and their quinone derivatives (PPD-Qs) are ubiquitous in the environment, while data on their occurrence in foods are scarce. In this study, twelve PPDs and PPD-Qs were measured in infant formula, and their daily intakes and health risks for infants were assessed. In the tested 141 samples, the median levels of ∑PPDs and ∑PPD-Qs were 2538 and 80.34 pg/g (powder), respectively. N-(1,3-Dimethylbutyl)- N ′-phenyl- p -phenylenediamine (6PPD) was detected in most samples, with a median level of 2125 pg/g. However, most other PPDs and all PPD-Qs presented low detection frequencies of <40%, with mean levels of <80 pg/g. Formulas for infants of 0–6 months had significantly higher levels of 6PPD than those for older infants. Estimated daily intakes (EDIs) of ∑PPDs and ∑PPD-Qs via formula feeding were < 200 and < 10 ng/kg bw/day, respectively, for infants, and formula feeding may represent an important dietary exposure pathway for infants.
No takes yet. Share an insight, caveat, or question.
Shao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: